Find stats on top websites
Industry Landscape
The healthcare AI industry is experiencing rapid growth, driven by advancements in machine learning and increasing demand for efficient and accurate diagnostic tools. It's transforming medical imaging, drug discovery, and patient care. Regulatory clearances and clinical validations are key to adoption, with a strong focus on improving workflow and patient outcomes. Competition is intense, but the market is expanding.
Total Assets Under Management (AUM)
Medical Imaging Market Size in United States
~Approx. 20.3 billion USD (2023)
(5-7% CAGR)
-Driven by technological advancements.
-Increasing prevalence of chronic diseases.
-Growing elderly population.
Total Addressable Market
30 billion USD
Market Growth Stage
Pace of Market Growth
Emerging Technologies
Federated Learning for Healthcare
Federated learning allows AI models to be trained on decentralized datasets without directly sharing raw patient data, addressing privacy concerns and enabling more robust, diverse models.
Generative AI in Medical Imaging
Generative AI can create synthetic medical images for training, augment existing datasets, or even assist in image reconstruction, enhancing data availability and model robustness.
Edge AI for Real-time Diagnostics
Deploying AI models directly on MRI machines or local servers enables real-time processing and immediate feedback, reducing latency and reliance on cloud infrastructure.
Impactful Policy Frameworks
FDA's AI/ML-Based Software as a Medical Device (SaMD) Action Plan (2021)
The FDA's Action Plan outlines its approach to regulate AI/ML-based SaMD, focusing on a 'Predetermined Change Control Plan' to allow modifications while ensuring safety and effectiveness.
This policy provides a clearer regulatory pathway for AI-driven medical devices like SwiftMR, potentially streamlining future updates and iterations of AIRS Medical's software.
European Union's Artificial Intelligence Act (Proposed, 2021-2024)
The EU AI Act proposes a risk-based approach to AI regulation, classifying AI systems, including those in healthcare, as 'high-risk' and imposing strict requirements on their development and deployment.
AIRS Medical will need to ensure SwiftMR's compliance with stringent requirements for high-risk AI systems if expanding further into the EU, impacting development and market access strategies.
Health Insurance Portability and Accountability Act (HIPAA) (Updated, 2013-present)
HIPAA mandates national standards for the protection of sensitive patient health information, requiring safeguards for data privacy and security.
Continued adherence to HIPAA's strict data privacy and security regulations is paramount for AIRS Medical, particularly as AI solutions process vast amounts of patient imaging data.
Transform Your Ideas into Action in Minutes with WaxWing
Sign up now and unleash the power of AI for your business growth
